510(k) Report

510(k) · Cleared

Cleared

Hailie Sensor

K181405510(k) TraditionalCleared Dec 10, 2018195-day reviewClass II21 CFR 868.5630

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Adherium (Nz), Ltd. · CAF Nebulizer (Direct Patient Interface)

Cleared on Dec 10, 2018 as substantially equivalent to K173310 (Adherium (Nz), Ltd., 2018) after a 195-day review. Its family tree reaches back 6 generations to 1982.

Decided
Dec 10, 2018
Review
195 days
Class
Class II
Product code
CAF
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K823423 (1982). 9 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 6 generations backK823423 Nebulizer Chronolog & InterpreterAdvanced Technology Products, Inc. · 1982
  2. 5 generations backK970344 Mdilog, Model MDC-511Medtrak Technologies, Inc. · 1997
  3. 4 generations backK091803 Smarttrack SystemNexus6, Ltd. · 2009
  4. 3 generations backK133951 SmarttouchNexus6, Ltd. · 2014
  5. 2 generations backK163485 SmartTouchAdherium (Nz), Ltd. · 2017
  6. 1 generation backK173310 SmartTouchAdherium (Nz), Ltd. · 2018
  7. This deviceK181405 Hailie SensorAdherium (Nz), Ltd. · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K823423Nebulizer Chronolog & InterpreterAdvanced Technology Products, Inc.1982—
−5K970344Mdilog, Model MDC-511Medtrak Technologies, Inc.1997—
−4K091803Smarttrack SystemNexus6, Ltd.2009—
−3K133951SmarttouchNexus6, Ltd.2014—
−2K163485SmartTouchAdherium (Nz), Ltd.2017—
−1K173310SmartTouchAdherium (Nz), Ltd.2018—
0 (this device)K181405Hailie SensorAdherium (Nz), Ltd.2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199420
199910
FIG. 1 — Lineage of K181405, 1982–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CAF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CAF device

  1. #1 K260270 FindAir ONE for pMDI (FAO-MDI-V12-GRE-001)score 13.2 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K173310SmartTouch
Summary page 4
…esiology Devices, 21 CFR 868.5630, Class II, CAF (a)(3) Identification of Legally Marketed Devices The predicate device to which substantial equivalence is claimed is: K173310, SmartTouch™, manufactured by Adherium (NZ) Limited. The reference device which supports a substantial equivalence determination…
Adherium (Nz), Ltd.2018—
†K133951SmarttouchNexus6, Ltd.2014—

Also cleared against K173310: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 36 years and passes through 4 companies; a new generation was cleared every 4.5 years on median.
  • None of the 9 ancestors has a recall.
  • 1 other device also cites its predicate K173310.

How does its category compare?

All CAF devices

CAF Nebulizer (Direct Patient Interface): FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · CAF

7in 2025

2007: 182008: 122009: 82010: 102011: 102012: 92013: 92014: 92015: 82016: 52017: 82018: 92019: 32020: 62021: 82022: 42023: 82024: 42025: 72026 (partial year): 2
2007high 18 (2007) · low 3 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CAF

211in 2025

2007: 98 days median2008: 123 days median2009: 163 days median2010: 114 days median2011: 157 days median2012: 126 days median2013: 238 days median2014: 151 days median2015: 186 days median2016: 186 days median2017: 253 days median2018: 161 days median2019: 266 days median2020: 219 days median2021: 324 days median2022: 176 days median2023: 279 days median2024: 251 days median2025: 211 days median
2007high 324 (2021) · low 98 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CAF

1in 2018

2007: 12011: 12014: 52015: 32016: 12017: 14, 13 Class I2018: 1
2007high 14 (2017) · low 0 (2008)2026

Class I (13 since 2007) Class II/III not classified

Adverse event reports per year · CAF

191in 2025

2007: 262008: 112009: 152010: 372011: 2372012: 1382013: 2172014: 1232015: 1662016: 2012017: 2562018: 1622019: 1852020: 1172021: 1612022: 552023: 1072024: 1022025: 191
2007high 256 (2017) · low 11 (2008)2025

MAUDE reports naming product code CAF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071898126
200812123011
20098163015
201010114037
2011101571237
201291260138
201392380217
201491515123
201581863166
201651861201
2017825314 (13)256
201891611162
201932660185
202062190117
202183240161
20224176055
202382790107
202442510102
202572110191
20262—0—

What is it indicated for?

The Hailie™ sensor is intended for single-patient use in the home environment as a medication reminder and electronic data capture accessory for recording actuations of prescribed inhaler usage. This may be used in the following applications: * In clinical trials, where researchers need to know when a patient has actuated their trial inhaler medication. * In clinical practice, where specialists, general practitioners, nurses, and educators need to know…

Read the full statement (132 words)

The Hailie™ sensor is intended for single-patient use in the home environment as a medication reminder and electronic data capture accessory for recording actuations of prescribed inhaler usage. This may be used in the following applications:

* In clinical trials, where researchers need to know when a patient has actuated their trial inhaler medication.

* In clinical practice, where specialists, general practitioners, nurses, and educators need to know if a patient has actuated their prescribed inhaler medication.

* In self-management, where patients need to track their medication use as part of their management plan.

The Hailie™ sensor is compatible only with Bevespi Aerosphere® and is for use by adults. The Hailie™ sensor is not intended to indicate remaining quantity of medication in an inhaler and does not include a dose counting function.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K181405: Hailie Sensor.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K181405

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026